Home / Business and Economy / Agilent Buys Biocare Medical for $950M
Agilent Buys Biocare Medical for $950M
9 Mar
Summary
- Agilent Technologies is acquiring Biocare Medical for $950 million.
- The deal is an all-cash transaction expected to close by Q4 2026.
- Biocare Medical provides integrated tissue diagnostic products.
Life sciences firm Agilent Technologies has announced an agreement to acquire Biocare Medical, a privately held company specializing in clinical pathology. The all-cash transaction is valued at $950 million.
Biocare Medical, headquartered in California, is being acquired from Excellere Partners and GHO Capital Partners. The deal is anticipated to be finalized by the fourth fiscal quarter of 2026. Following the acquisition, Biocare Medical will be integrated into Agilent's Life Sciences and Diagnostics Markets business unit.
The acquired company offers a portfolio of integrated tissue diagnostic products, which are crucial for the diagnosis of cancer and infectious diseases. Biocare Medical's existing customer base includes government and military laboratories, suggesting a strong market presence in critical diagnostic areas.
